Foodborne Illness Acquired in the United States—Major Pathogens by Scallan, Elaine et al.
Estimates of foodborne illness can be used to direct 
food safety policy and interventions. We used data from ac-
tive and passive surveillance and other sources to estimate 
that each year 31 major pathogens acquired in the United 
States caused 9.4 million episodes of foodborne illness 
(90% credible interval [CrI] 6.6–12.7 million), 55,961 hos-
pitalizations (90% CrI 39,534–75,741), and 1,351 deaths 
(90% CrI 712–2,268). Most (58%) illnesses were caused 
by norovirus, followed by nontyphoidal Salmonella spp. 
(11%), Clostridium perfringens (10%), and Campylobacter
spp. (9%). Leading causes of hospitalization were nonty-
phoidal Salmonella spp. (35%), norovirus (26%), Campy-
lobacter spp. (15%), and Toxoplasma gondii (8%). Leading 
causes of death were nontyphoidal Salmonella spp. (28%), 
T. gondii (24%), Listeria monocytogenes (19%), and norovi-
rus (11%). These estimates cannot be compared with prior 
(1999) estimates to assess trends because different meth-
ods were used. Additional data and more reﬁ  ned methods 
can improve future estimates.
E
stimates of the overall number of episodes of foodborne 
illness are helpful for allocating resources and priori-
tizing interventions. However, arriving at these estimates 
is challenging because food may become contaminated 
by many agents (e.g., a variety of bacteria, viruses, para-
sites, and chemicals), transmission can occur by nonfood 
mechanisms (e.g., contact with animals or consumption of 
contaminated water),  the proportion of disease transmitted 
by food differs by pathogen and by host factors (e.g. age 
and immunity),  and only a small proportion of illnesses 
are con   rmed by laboratory testing and reported to public 
health agencies.
Laboratory-based surveillance provides crucial infor-
mation for assessing foodborne disease trends. However, 
because only a small proportion of illnesses are diagnosed 
and reported, periodic assessments of total episodes of ill-
ness are also needed. (Hereafter, episodes of illness are 
referred to as illnesses.) Several countries have conducted 
prospective population-based or cross-sectional studies to 
supplement surveillance and estimate the overall number of 
foodborne illnesses (1). In 2007, the World Health Organi-
zation launched an initiative to estimate the global burden 
of foodborne diseases (2).
In 1999, the Centers for Disease Control and Prevention 
provided comprehensive estimates of foodborne illnesses, 
hospitalizations, and deaths in the United States caused by 
known and unknown agents (3). This effort identi   ed many 
data gaps and methodologic limitations. Since then, new 
data and methods have become available. This article is 1 
of 2 reporting new estimates of foodborne diseases acquired 
in the United States (hereafter referred to as domestically 
acquired). This article provides estimates of major known 
pathogens; the other provides estimates for agents of acute 
gastroenteritis not speci   ed in this article (4).
Methods
Adequate data for preparing national estimates were 
available for 31 pathogens. We estimated the number of 
foodborne illnesses, hospitalizations, and deaths caused 
by these 31 domestically acquired pathogens by using data 
shown in the online Appendix Table (www.cdc.gov/EID/
content/17/1/7-appT.htm) and online Technical Appendix 
1 (www.cdc.gov/EID/content/17/1/7-Techapp1.pdf).
Data were mostly from 2000–2008, and all estimates 
were based on the US population in 2006 (299 million per-
sons). Estimates were derived from statistical models with 
many inputs, each with some measure of uncertainty (5). 
To re   ect this uncertainty, we used probability distribu-
tions to describe a range of plausible values for all model 
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inputs. We expressed model outputs as probability distri-
butions summarized by a mean point estimate with 90% 
credible intervals (CrIs). We used 2 types of modeling ap-
proaches for different types of data: 1) models that began 
with counts of laboratory-con   rmed illnesses and were ad-
justed for undercounts (because of underreporting and un-
derdiagnosis) and thus scaled up to the estimated number 
of illnesses and 2) models that began with a US popula-
tion and used incidence data to scale down to the estimated 
number of illnesses (Table 1). The modeling approaches 
used and parameters of these probability distributions are 
detailed in online Technical Appendixes 2 and 3 (www.
cdc.gov/EID/content/17/1/7-Techapp2.pdf and www.cdc.
gov/EID/content/17/1/7-Techapp3.pdf, respectively); the 
proportions cited are modal values.
Illnesses
Laboratory-based surveillance data were available 
for 25 pathogens (online Appendix Table). The following 
events must occur for an illness to be ascertained and in-
cluded in laboratory-based surveillance: the ill person must 
seek medical care, a specimen must be submitted for labo-
ratory testing, the laboratory must test for and identify the 
causative agent, and the illness must be reported to public 
health authorities. If a break occurs in any of the    rst 3 
steps of this surveillance chain, the causative agent will not 
be laboratory con    rmed (underdiagnosis). Furthermore, 
although all laboratory-con    rmed illnesses are reported 
by active surveillance, some will not be reported by pas-
sive surveillance (underreporting). Therefore, to estimate 
the number of illnesses caused by pathogens under public 
health surveillance, we determined the number of labora-
tory-con   rmed illnesses and adjusted for underdiagnosis 
and, if necessary, for underreporting by using a series of 
component multipliers.
Laboratory-con    rmed illnesses for these 25 patho-
gens were reported through 5 surveillance programs: the 
Foodborne Diseases Active Surveillance Network (Food-
Net) for Campylobacter spp., Cryptosporidium spp., Cy-
clospora cayetanensis, Shiga toxin–producing Escherichia
coli (STEC) O157, STEC non-O157, Listeria monocyto-
genes, nontyphoidal Salmonella spp., Salmonella enterica 
serotype Typhi, Shigella spp., and Yersinia enterocolit-
ica; the National Noti    able Diseases Surveillance Sys-
tem (NNDSS) for Brucella spp., Clostridium botulinum, 
Trichinella spp., hepatitis A virus, and Giardia intestinalis; 
the Cholera and Other Vibrio Illness Surveillance (COVIS) 
system for toxigenic Vibrio cholerae, V. vulniﬁ  cus, V. para-
hemolyticus, and other Vibrio spp.; the National Tuberculo-
sis Surveillance System (NTSS) for Mycobacterium bovis; 
and the Foodborne Disease Outbreak Surveillance System 
(FDOSS) for Bacillus cereus, Clostridium perfringens, en-
terotoxigenic E. coli (ETEC), Staphylococcus aureus, and 
Streptococcus spp. group A (online Appendix Table; online 
Technical Appendix 1). When data were available from >1 
surveillance system, we used active surveillance data from 
FoodNet, except for Vibrio spp., for which we used COVIS 
because of geographic clustering of Vibrio spp. infections 
outside FoodNet sites. We used data on outbreak-associat-
ed illnesses from FDOSS only for pathogens for which no 
data were available from other systems.
Because FoodNet conducts surveillance at 10 sites (6), 
we estimated the number of laboratory-con   rmed illnesses 
in the United States by applying incidence from FoodNet to 
the estimated US population for 2006 (7). We constructed 
a probability distribution based on extrapolation of rates 
by year (2005–2008) in each FoodNet site (online Techni-
cal Appendix 3). We used data from 2005–2008 because 
the FoodNet surveillance area was constant during that 
period and because FoodNet began collecting information 
on foreign travel in 2004. We used data from 2000–2007 
for NNDSS, COVIS, and FDOSS and annual counts of 
reported illnesses for our probability distributions. Some 
evidence of trend was found for illness caused by hepatitis 
A virus, S. aureus, and Vibrio spp.; therefore, recent years 
were weighted more heavily (online Technical Appendixes 
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Table 1. Modeling approaches used to estimate the total number of illnesses for different types of data, United States* 
Pathogens for which laboratory-confirmed illnesses were scaled up  Pathogens for which US 
population was scaled down  Active surveillance data  Passive surveillance data  Outbreak surveillance data 
Campylobacter spp. Brucella spp.  Bacillus cereus Astrovirus
Cryptosporidium spp.  Clostridium botulinum Clostridium perfringens Norovirus
Cyclospora cayetanensis Giardia intestinalis ETEC† Rotavirus
STEC O157  Hepatitis A virus  Staphylococcus aureus Sapovirus
STEC non-O157  Mycobacterium bovis Streptococcus spp. group A  Toxoplasma gondii
Listeria monocytogenes Trichinella spp. 
Salmonella spp., nontyphoidal‡  Vibrio cholera, toxigenic 
S. enterica serotype Typhi  Vibrio parahaemolyticus
Shigella spp.  Vibrio vulnificus
Yersinia enterocolitica Vibrio spp., other 
*ETEC, enterotoxigenic Escherichi coli; STEC, Shiga toxin–producing E. coli.
†Numbers of E. coli other than STEC or ETEC assumed to be same as for ETEC.  
‡Includes all serotypes other than Typhi. Foodborne Illness, USA—Major Pathogens
2, 3). NTSS was used to determine the number of reported 
illnesses caused by M. bovis during 2004–2007.
We assumed that all laboratory-con   rmed  illnesses 
were reported to FoodNet active surveillance in the rel-
evant catchment areas. Because COVIS and NNDSS 
conduct passive surveillance, we applied an underreport-
ing multiplier (1.1 for bacteria and 1.3 for parasites) de-
rived by comparing incidence of all nationally noti   able 
illnesses ascertained through FoodNet with that reported 
to NNDSS (online Technical Appendix 4, www.cdc.gov/
EID/content/17/1/7-Techapp4.pdf). For the 5 bacteria for 
which only outbreak data were available, we estimated the 
number of laboratory-con   rmed illnesses by creating an 
underreporting multiplier as follows. We determined the 
proportion of illnesses ascertained through FoodNet that 
were caused by Campylobacter spp., Cryptosporidium 
spp., C. cayatanensis, L. monocytogenes, Salmonella spp., 
Shigella spp., STEC, Vibrio spp., and Y. enterocolitica that 
were also reported to FDOSS as outbreak associated and 
applied the inverse of this proportion, 25.5, to those patho-
gens (online Technical Appendix 4). We assumed that all 
illnesses caused by M. bovis were reported to NTSS.
To adjust for underdiagnosis resulting from variations 
in medical care seeking, specimen submission, laboratory 
testing, and test sensitivity, we created pathogen-speci   c 
multipliers. To adjust for medical care seeking and speci-
men submission, we pooled data from FoodNet Popula-
tion Surveys in 2000–2001, 2002–2003 (8), and 2006–
2007 (Centers for Disease Control and Prevention, unpub. 
data) from which we estimated the proportion of persons 
who in the past month reported an acute diarrheal illness 
(>3 loose stools in 24 hours lasting >1 day or resulting 
in restricted daily activities) and sought medical care and 
submitted a stool sample for that illness. Because persons 
with more severe illness are more likely to seek care (9), 
we estimated pathogen-speci    c proportions of persons 
with laboratory-con   rmed infections who had severe ill-
ness (e.g., bloody diarrhea) and used medical care seeking 
and stool sample submission rates for bloody (35% and 
36%, respectively) and nonbloody (18% and 19%, respec-
tively) diarrhea as surrogates for severe and mild cases of 
most illnesses (online Technical Appendix 3). However, 
for infections with L. monocytogenes, M. bovis, and V. 
vulniﬁ  cus and severe infections with hepatitis A virus, we 
assumed high rates of medical care seeking (i.e., we as-
sumed that 100% of persons with M. bovis infection and 
90% with L. monocytogenes, V. vulniﬁ  cus, or severe hepa-
titis A virus infections sought care) and specimen submis-
sion (100% for hepatitis A virus and M. bovis, 80% for 
others). We accounted for percentage of laboratories that 
routinely tested for speci   c pathogens (25%–100%) and 
test sensitivity (28%–100%) by using data from FoodNet 
(10,11) and other surveys of clinical diagnostic labora-
tory practices (online Technical Appendix 3). For the 5 
pathogens for which data were from outbreaks only, we 
used the nontyphoidal Salmonella spp. underdiagnosis 
multiplier.
Alternative approaches were used for infections not 
routinely reported by any surveillance system (i.e., diar-
rheagenic E. coli other than STEC and ETEC, T. gondii, 
astrovirus, rotavirus, sapovirus, and norovirus) (online 
Technical Appendixes 1–3). We assumed diarrheagenic 
E. coli other than STEC and ETEC to be as common as 
ETEC. Illnesses caused by T. gondii were estimated by us-
ing nationally representative serologic data from the 1999–
2004 National Health and Nutrition Examination Survey 
(12) and an estimate that clinical illness develops in 15% 
of persons who seroconvert (13). We assumed that 75% 
of children experience an episode of clinical rotavirus ill-
ness by 5 years of age, consistent with    ndings from other 
studies (14), and used this estimate for astrovirus and sapo-
virus. We estimated norovirus illnesses by applying mean 
proportion of all acute gastroenteritis caused by norovirus 
(11%) according to studies in other industrialized countries 
(15–18) to estimates of acute gastroenteritis from FoodNet 
Population Surveys (online Appendix Table; online Tech-
nical Appendixes 1–3) (4).
Hospitalizations and Deaths
For most pathogens, numbers of hospitalizations and 
deaths were estimated by determining (from surveillance 
data) the proportion of persons who were hospitalized and 
the proportion who died and applying these proportions to 
the estimated number of laboratory-con   rmed illnesses (on-
line Appendix Table; online Technical Appendixes 1, 3). 
Rates of hospitalization and death caused by G. intestinalis
and T. gondii were based on the 2000–2006 Nationwide 
Inpatient Sample. Because some persons with illnesses that 
were not laboratory con   rmed would also have been hos-
pitalized and died, we doubled the number of hospitaliza-
tions and deaths to adjust for underdiagnosis, similar to the 
method used by Mead et al. (3) but applied an uncertainty 
distribution (online Technical Appendix 3). For diarrhe-
agenic E. coli other than STEC and ETEC, total numbers 
of hospitalizations and deaths were assumed to be the same 
as those for ETEC. For rotavirus, we used previous esti-
mates (14). For astrovirus and sapovirus, we assumed that 
the number was 25% that of rotavirus (19,20). Numbers of 
norovirus hospitalizations and deaths were determined by 
multiplying the estimated number of hospitalizations and 
deaths caused by acute gastroenteritis, estimated by using 
national data on outpatient visits resulting in hospitaliza-
tion, hospital discharge surveys, and death certi   cates (on-
line Appendix Table; online Technical Appendixes 1–3) 
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(4), by the same norovirus proportion (11%) used to esti-
mate illnesses (15–18).
Domestically Acquired Foodborne Illnesses
Data from published studies and surveillance were used 
to determine, for each pathogen, the proportion of illnesses 
acquired while the person had been traveling outside the 
United States (online Technical Appendixes 1, 3). The re-
maining proportion was considered domestically acquired. 
We based our estimates of the proportion of domestically 
acquired foodborne illnesses caused by each pathogen on 
data from surveillance, risk factor studies, and a literature 
review (online Technical Appendixes 1, 3).
Uncertainty Analysis
We used empirical data, when available, to de   ne entire 
distributions or parameters of distributions (online Techni-
cal Appendix 3). When data were sparse, we made reasoned 
judgments based on context, plausibility, and previously 
published estimates. The parametric distribution used for al-
most all multipliers was a 4-parameter beta (modi   ed PERT) 
distribution (21). The    rst 3 parameters are low, modal, and 
high. The fourth parameter is related to the variability of 
the distribution. We typically    xed this last parameter at 4, 
which yields the simple PERT distribution (21). However, 
when describing the outbreak reporting multiplier, we used 
a value of 20 (online Technical Appendix 4).
Uncertainty in the estimates is the cumulative effect 
of uncertainty of each of the model inputs. We iteratively 
generated sets of independent pathogen-speci   c  adjust-
ment factors and used these multipliers to estimate illness-
es, hospitalizations, and deaths (Figure; online Technical 
Appendix 2). On the basis of 100,000 iterations, we ob-
tained empirical distributions of counts corresponding to 
Bayesian posterior distributions and used these posterior 
distributions to generate a point estimate (posterior mean) 
and upper and lower 5% limits for 90% CrIs. Because in-
cidence of illnesses differed by location and over time, 
we included these variations in the models, which led to 
wider CrIs than if we had assumed that inputs represented 
independent random samples of a    xed US population. We 
used SAS version 9.2 (SAS Institute, Cary, NC, USA) for 
these analyses.
Results
Foodborne Illnesses
We estimate that each year in the United States, 31 
pathogens caused 37.2 million (90% CrI 28.4–47.6 mil-
lion) illnesses, of which 36.4 million (90% CrI 27.7–46.7 
million) were domestically acquired; of these, 9.4 mil-
lion (90% CrI 6.6–12.7 million) were foodborne (Table 
2; expanded version available online, www.cdc.gov/EID/
content/17/1/7-T2.htm). We estimate that 5.5 million 
(59%) foodborne illnesses were caused by viruses, 3.6 mil-
lion (39%) by bacteria, and 0.2 million (2%) by parasites. 
The pathogens that caused the most illnesses were noro-
virus (5.5 million, 58%), nontyphoidal Salmonella spp. 
(1.0 million, 11%), C. perfringens (1.0 million, 10%), and 
Campylobacter spp. (0.8 million, 9%).
Hospitalizations
We estimate that these 31 pathogens caused 228,744 
(90% CrI 188,326–275,601) hospitalizations annually, of 
which 55,961 (90% CrI 39,534–75,741) were caused by 
contaminated food eaten in the United States (Table 3; 
expanded version available online, www.cdc.gov/EID/
content/17/1/7-T3.htm). Of these, 64% were caused by 
bacteria, 27% by viruses, and 9% by parasites. The leading 
causes of hospitalization were nontyphoidal Salmonella 
spp. (35%), norovirus (26%), Campylobacter spp. (15%), 
and T. gondii (8%).
Deaths
We estimate that these 31 pathogens caused 2,612 
deaths (90% CrI 1,723–3,819), of which 1,351 (90% CrI 
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Figure. Example schematic diagram of the estimation and uncertainty model used to estimate episodes of illness, hospitalizations, and 
deaths in the United States. Count, data (empirical distribution); Year, factor to standardize non-2006 counts to 2006 (constant); Sub,
expansive factor to scale area surveillance to the entire US population (constant); Ob, expansive factor to scale outbreak counts up to 
outbreak plus sporadic counts (beta distribution); CS, expansive factor to scale care seekers to all ill, with severe and mild illness versions 
(PERT distribution); SS, expansive factor to scale submitted samples to all visits, with severe and mild illness versions (PERT distribution); 
PS, estimated proportion of illnesses that are severe (PERT distribution); LT, expansive factor to scale tests performed up to samples 
submitted (PERT distribution); LS, expansive factor to scale positive test results up to true positive specimens (PERT distribution); H,
contractive factor to scale illnesses down to hospitalized illnesses (PERT distribution); D, contractive factor to scale illnesses down to 
deaths (PERT distribution); F, contractive factor to scale illnesses down to foodborne illnesses (PERT distribution).Foodborne Illness, USA—Major Pathogens
712–2,268) were caused by contaminated food eaten in the 
United States (Table 3). Of these, 64% were caused by bac-
teria, 25% by parasites, and 12% by viruses. The leading 
causes of death were nontyphoidal Salmonella spp. (28%), 
T. gondii (24%), L. monocytogenes (19%), and norovirus 
(11%).
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Table 2. Estimated annual number of episodes of domestically acquired foodborne illnesses caused by 31 pathogens, United States*
Pathogen
Laboratory 
confirmed
Multipliers 
Travel
related, % 
Foodborne, 
%† 
Domestically acquired foodborne, 
mean (90% credible interval) 
Under-
reporting 
Under-
diagnosis
Bacteria
 Bacillus  cereus,  foodborne 85‡ 25.5 29.3 <1 100 63,400  (15,719–147,354) 
 Brucella  spp. 120§ 1.1 15.2 16 50 839 (533–1,262) 
 Campylobacter  spp. 43,696¶ 1.0 30.3 20 80 845,024 (337,031–1,611,083) 
 Clostridium  botulinum,   
foodborne 
25§ 1.1 2.0 <1 100 55 (34–91) 
  Clostridium perfringens,  
foodborne 
1,295‡ 25.5 29.3 <1 100 965,958  (192,316–2,483,309) 
STEC O157  3,704¶ 1.0 26.1 4 68 63,153 (17,587–149,631) 
STEC non-O157  1,579¶ 1.0 106.8  18 82 112,752 (11,467–287,321) 
ETEC, foodborne 53‡ 25.5 29.3 55 100 17,894 (24–46,212) 
Diarrheagenic E. coli  
other than STEC and ETEC
53 25.5 29.3 <1 30 11,982 (16–30,913) 
 Listeria  monocytogenes 808¶ 1.0 2.1 3 99 1,591 (557–3,161) 
 Mycobacterium  bovis 195¶ 1.0 1.1 70 95 60 (46–74) 
 Salmonella  spp., nontyphoidal 41,930¶ 1.0 29.3 11 94 1,027,561 (644,786–1,679,667) 
 S.  enterica  serotype Typhi 433¶ 1.0 13.3 67 96 1,821 (87–5,522) 
 Shigella  spp. 14,864¶ 1.0 33.3 15 31 131,254 (24,511–374,789) 
 Staphylococcus  aureus,   
foodborne 
323‡ 25.5 29.3 <1 100 241,148  (72,341–529,417) 
 Streptococcus  spp. group A,  
 foodborne
15‡ 25.5 29.3 <1 100 11,217 (15–77,875) 
 Vibrio  cholerae,  toxigenic 8§ 1.1 33.1 70 100 84 (19–213) 
 V.  vulnificus 111§ 1.1 1.7 2 47 96  (60–139) 
 V.  parahaemolyticus 287§ 1.1 142.4  10 86 34,664  (18,260–58,027) 
 Vibrio  spp., other 220§ 1.1 142.7  11 57 17,564  (10,848–26,475) 
 Yersinia  enterocolitica 950¶ 1.0 122.8 7 90 97,656  (30,388–172,734) 
Subtotal 3,645,773 (2,321,468–5,581,290) 
Parasites
 Cryptosporidium spp.  7,594¶ 1.0 98.6 9 8 57,616 (12,060–166,771) 
 Cyclospora  cayetanensis 239¶ 1.0 83.1 42 99 11,407 (137–37,673) 
 Giardia  intestinalis 20,305§ 1.3 46.3 8 7 76,840  (51,148–109,739) 
 Toxoplasma  gondii 1.0 0.0 <1 50 86,686 (64,861–111,912) 
 Trichinella spp.  13§ 1.3 9.8 4 100 156 (42–341) 
Subtotal 232,705 (161,923–369,893) 
Viruses
 Astrovirus  NA NA NA 0 <1 15,433  (5,569–26,643) 
  Hepatitis A virus  3,576§  1.1 9.1 41 7 1,566 (702–3,024) 
 Norovirus  NA NA NA <1 26 5,461,731  (3,227,078–8,309,480) 
 Rotavirus  NA NA NA 0 <1 15,433  (5,569–26,643) 
 Sapovirus  NA NA NA 0 <1 15,433  (5,569–26,643) 
Subtotal 5,509,597 (3,273,623–8,355,568) 
Total 9,388,075
(6,641,440–12,745,709) 
*All estimates based on US population in 2006. Modal or mean value shown unless otherwise stated; see online Technical Appendix 3 
(www.cdc.gov/EID/content/17/1/7-Techapp3.pdf) for the parameters of these distributions. STEC, Shiga toxin–producing Escherichia coli; ETEC, 
enterotoxigenic E. coli; NA, not applicable. An expanded version of this table is available online (www.cdc.gov/EID/content/17/1/7-T2.htm). 
†Percentage foodborne among domestically acquired illnesses.  
‡Passive surveillance data on outbreak-associated illnesses from the Foodborne Disease Outbreak Surveillance System. Estimates based on the number 
of foodborne illnesses ascertained in surveillance and therefore assumed to reflect only foodborne transmission. 
§Passive surveillance data from Cholera and Other Vibrio Illness Surveillance or the National Notifiable Disease Surveillance System.  
¶Active surveillance data from Foodborne Diseases Active Surveillance Network, adjusted for geographic coverage; data from the National Tuberculosis 
Surveillance System for M. bovis.RESEARCH
Discussion
We estimate that foods consumed in the United States 
that were contaminated with 31 known agents of foodborne 
disease caused 9.4 million illnesses, 55,961 hospitaliza-
tions, and 1,351 deaths each year. Norovirus caused the 
most illnesses; nontyphoidal Salmonella spp., norovirus, 
Campylobacter spp., and T. gondii caused the most hos-
pitalizations; and nontyphoidal Salmonella spp., T. gondii, 
L. monocytogenes, and norovirus caused the most deaths. 
Scarce data precluded estimates for other known infectious 
and noninfectious agents, such as chemicals. Foodborne 
diseases are also caused by agents not yet recognized as 
being transmitted in food and by unknown agents (22). The 
numbers of illnesses caused by these unspeci   ed agents are 
estimated elsewhere (4).
Studies estimating the overall number of foodborne 
illnesses have been conducted in England and Wales and 
in Australia (23,24). Similar to our    ndings, in Australia 
norovirus was the leading cause of foodborne illness, ac-
counting for 30% of illnesses caused by known pathogens. 
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Table 3. Estimated annual number of domestically acquired foodborne hospitalizations and deaths caused by 31 pathogens, United 
States*
Pathogen 
Hospitalization
rate, %† 
Hospitalizations, mean 
(90% credible interval) 
Death
rate, %† 
Deaths, mean  
(90% credible interval) 
Bacteria
 Bacillus  cereus,  foodborne‡   0.4 20 (0–85)  0 0
 Brucella  spp. 55.0 55 (33–84)  0.9 1 (0–2) 
 Campylobacter  spp. 17.1 8,463 (4,300–15,227)  0.1 76 (0–332) 
 Clostridium  botulinum,  foodborne‡   82.6 42 (19–77)  17.3 9 (0–51) 
 Clostridium  perfringens,  foodborne‡   0.6 438 (44–2,008)  <0.1 26 (0–163) 
STEC O157  46.2 2,138 (549–4,614)  0.5 20 (0–113) 
STEC non-O157  12.8 271 (0–971)  0.3 0 (0–0)§ 
ETEC, foodborne 0.8 12 (0–53)  0 0
Diarrheagenic E. coli other than STEC and ETEC 0.8 8 (0–36)  0 0
 Listeria  monocytogenes 94.0 1,455 (521–3,018)  15.9 255 (0–733) 
 Mycobacterium  bovis 55.0 31 (21–42)  4.7 3 (2–3) 
 Salmonella  spp., nontyphoidal 27.2 19,336 (8,545–37,490)  0.5 378 (0–1,011) 
 S.  enterica  serotype Typhi 75.7 197 (0–583)  0 0
 Shigella  spp.  20.2 1,456 (287–3,695)  0.1 10 (0–67) 
 Staphylococcus  aureus, foodborne‡   6.4 1,064 (173–2,997)  <0.1 6 (0–48) 
 Streptococcus  spp. group A, foodborne‡  0.2 1 (0–6)  0 0
 Vibrio  cholerae,  toxigenic 43.1 2 (0–5) 0 0
 V.  vulnificus 91.3 93 (53–145)  34.8 36 (19–57) 
 V.  parahaemolyticus 22.5 100 (50–169)  0.9 4 (0–17) 
 Vibrio  spp., other  37.1 83 (51–124)  3.7 8 (3–19) 
 Yersinia  enterocolitica 34.4 533 (0–1,173)  2.0 29 (0–173) 
Subtotal 35,796 (21,519–53,414)  861 (260–1,761) 
Parasites
 Cryptosporidium  spp. 25.0 210 (58–518)  0.3 4 (0–19) 
 Cyclospora  cayetanensis 6.5 11 (0–109) 0.0 0
 Giardia  intestinalis 8.8 225 (141–325)  0.1 2 (1–3) 
 Toxoplasma  gondii 2.6 4,428 (2,634–6,674)  0.2 327 (200–482) 
 Trichinella  spp. 24.3 6 (0–17)  0.2 0 (0–0) 
Subtotal 4,881 (3,060–7,146)  333 (205–488) 
Viruses
 Astrovirus  0.4 87  (32–147)  <0.1 0
  Hepatitis A virus  31.5 99 (42–193)  2.4 7 (3–15) 
  Norovirus  0.03 14,663 (8,097–23,323)  <0.1 149 (84–237) 
 Rotavirus  1.7 348  (128–586)  <0.1 0
 Sapovirus  0.4 87  (32–147)  <0.1 0
Subtotal 15,284 (8,719–23,962)  157 (91–245) 
Total 55,961 (39,534–75,741)  1,351 (712–2,268) 
*All estimates were based on US population in 2006. STEC, Shiga toxin–producing Escherichia coli; ETEC, enterotoxigenic E. coli. An expanded version 
of this table is available online (www.cdc.gov/EID/content/17/1/7-T3.htm). 
†For laboratory-confirmed illnesses. Unadjusted hospitalization and death rates are presented here. These rates were doubled to adjust for 
underdiagnosis before being applied to the number of laboratory-confirmed cases to estimate the total number of hospitalizations and deaths. The 
hospitalization and death rates for astrovirus, norovirus, rotavirus, and sapovirus presented here are the percentage of total estimated illness and were 
not subject to further adjustment.  
‡Estimates based on the number of foodborne illnesses ascertained in surveillance, therefore assumed to reflect only foodborne transmission. 
§We report median values instead of means for the distributions of deaths caused by STEC non-O157 because of extremely skewed data. Foodborne Illness, USA—Major Pathogens
In England and Wales, norovirus accounted for only 8% of 
known foodborne illnesses; however, stool sample reexami-
nation using molecular techniques documented higher rates 
(18). Nontyphoidal Salmonella spp. and Campylobacter 
spp. were leading causes of foodborne illnesses in all 3 
countries (England and Wales, Australia, and the United 
States), although nontyphoidal Salmonella spp. accounted 
for a greater proportion of illness in the United States. Re-
cent serologic data from Europe suggest that Salmonella 
spp. infections are more common than estimated by our 
methods; however, many infections may be asymptomatic 
(25). Our estimates did not capture mild illnesses associat-
ed with some pathogens. For example, mild cases of botu-
lism are often recognized as part of outbreaks, but affected 
persons seldom seek medical care and are not captured by 
surveillance except during outbreaks (26,27). Likewise, 
L. monocytogenes is rarely diagnosed as the cause of gas-
troenteritis and fever, partly because this organism is not 
detected by routine stool culture (28). Early spontaneous 
abortion or miscarriage associated with listeriosis may also 
be underdiagnosed.
Accurately estimating hospitalizations and deaths 
caused by foodborne pathogens is particularly challeng-
ing. National data on outpatient visits resulting in hospi-
talization, hospital discharges, and death certi   cates prob-
ably substantially underestimate pathogen-speci   c  cases 
because for pathogen-speci   c diagnoses to be recorded, 
health care providers must order the appropriate diagnostic 
tests and coding must be accurate. Particularly in vulnera-
ble populations, dehydration or electrolyte imbalance from 
a gastrointestinal illness may exacerbate a chronic illness, 
resulting in hospitalization or death well after resolution of 
the gastrointestinal illness; thus, the gastrointestinal illness 
may not be coded as a contributing factor. Moreover, if a 
pathogen is not detected, infections may be coded as non-
infectious illnesses (29). For norovirus, we estimated the 
number of hospitalizations and deaths by applying the es-
timated proportion of acute gastroenteritis illnesses caused 
by norovirus to overall estimates of hospitalizations and 
deaths from acute gastroenteritis; this choice is supported 
by studies of hospitalizations for norovirus (30,31). For 
most other pathogens, we used data from surveillance to 
estimate pathogen-speci   c hospitalizations and deaths and 
doubled the numbers to adjust for underdiagnosis. More 
precise information about the degree of undercounting of 
hospitalizations and deaths for each pathogen would im-
prove these estimates.
Our methods and data differed from those used for 
the 1999 estimates (3). Our estimate of medical care seek-
ing among persons with a diarrheal illness, derived from 
the 3 most recent FoodNet Population Surveys conducted 
during 2000–2007, was higher than that estimated from 
the 1996–1997 FoodNet Population Survey used for the 
1999 estimates (35% and 18% among persons reporting 
bloody and nonbloody diarrhea, respectively, compared 
with 15% and 12% in the earlier [1999] study) (8). These 
data resulted in lower underdiagnosis multipliers, which 
contributed to lower estimates of number of illnesses. The 
biggest change from the earlier estimate was the estimated 
number of norovirus illnesses, which decreased for 2 rea-
sons. First, the number of acute gastrointestinal illnesses 
estimated from the FoodNet Population Survey and used 
in the current study was lower than the estimated number 
of acute gastrointestinal illnesses used in the 1999 assess-
ment. The earlier study used data from 1996–1997; the 
sample size was one    fth as large as ours and incorporated 
data from US studies conducted before 1980 (32,33). Both 
estimates excluded persons reporting concurrent cough or 
sore throat, but the proportion of persons reporting these 
signs and symptoms was higher in the FoodNet Popula-
tion Surveys we used than that in the older US studies 
(38% vs. 25%), contributing to a lower estimated preva-
lence of acute gastroenteritis (0.60 vs. 0.79 episodes/
person/year) (4,32,33). Additionally, the current study 
excluded persons with vomiting who were ill for <1 day 
or whose illness did not result in restricted daily activities, 
whereas the earlier study included all vomiting episodes. 
These factors contributed to the new estimate of acute 
gastroenteritis being 24% lower than the earlier estimate, 
more likely the result of increased accuracy than a true de-
crease in illnesses (4). Second, the lower current estimate 
for norovirus illnesses resulted from a lower proportion of 
norovirus estimated to be foodborne (decreased from 40% 
to 26%); this lower proportion is similar to that estimated 
in recent studies from other countries (23,24). Because of 
these reasons and use of other data sources and methods, 
our estimate cannot be compared with the 1999 estimate 
for the purpose of assessing trends. FoodNet provides the 
best data on trends over time (34).
Data used in the current study came from a variety of 
sources and were of variable quality and representativeness. 
FoodNet sites, from which we used data for 10 pathogens, 
are not completely representative of the US population, but 
1 study indicated that demographic data from FoodNet and 
from the 2005 US census did not differ much (6). For 5 
pathogens, only data on foodborne outbreak–related cases 
were available. No routine surveillance data were available 
for most viruses, forcing us to use a different modeling ap-
proach for viruses than for most other pathogens. Given 
the large number of norovirus illnesses in these estimates, 
the paucity of supporting data is a major limitation. More-
over, combining different methods is not optimal because 
methods themselves may affect the estimates. We chose 
our modeling approach and used the PERT distribution for 
many inputs because data were sometimes limited and sub-
jective decisions were required. Other investigators could 
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have chosen other distributions, for good reasons, and ar-
rived at different estimates.
Our assumptions about the proportion of illnesses 
transmitted by food profoundly affect our estimates, but 
data on which to base these estimates were often lacking. 
We used data from surveillance, risk factor studies, and the 
current literature to estimate the proportion of pathogen-
speci   c illnesses caused by consumption of contaminated 
food (35), but it is not known how representative these data 
are of total illnesses and whether the foodborne propor-
tion is similar across age groups. For example, the propor-
tion of some illnesses acquired from animals (e.g., STEC 
O157) may be higher among children than adults (36), and 
the proportions that spread person-to-person (e.g., norovi-
rus) may be higher among institutionalized elderly persons 
(37). Because a higher proportion of cases are reportedly 
associated with hospitalization or death in these vulnerable 
groups, we may have overestimated the total contribution 
of foodborne transmission for these outcomes.
The methods used for this study could be adapted to 
estimate the proportion of illnesses attributable to other 
modes of transmission, such as waterborne and direct ani-
mal contact. The estimates from this study can be used to 
help direct policy and interventions; to conduct other anal-
yses (e.g., evaluation of economic cost of these diseases 
and attribution to various food commodities); and as a plat-
form for developing estimates of effects of disease caused 
by sequelae of foodborne infections.
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